Reaction Details Report a problem with these data
Target
Beta-lactamase
Ligand
BDBM360930
Substrate
n/a
IC50
0.076±n/a nM
Citation
Bennett, F; Jiang, J; Pasternak, A; Dong, S; Gu, X; Scott, JD; Tang, H; Zhao, Z; Huang, Y; Yang, D; Young, K; Xiao, L; Zhang, Z; Fu, J Metallo-beta-lactamase inhibitors US Patent US10544130 Publication Date 1/28/2020
More Info.:
Target
Name:
Beta-lactamase
Synonyms:
n/a
Type:
Protein
Mol. Mass.:
29508.45
Organism:
n/a
Description:
Q2QC95
Residue:
266
Sequence:
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
Inhibitor
Name:
BDBM360930
Synonyms:
4-(2- aminobenzo [d]thiazol- 4-yl)-N1-((4- hydroxypiperidin- 4-yl)methyl)- 3-(1H- tetrazol-5-yl) benzene-1,2- disulfonamide | US10221163, Example 86 | US10544130, Example 86
Type:
Small organic molecule
Emp. Form.:
C20H23N9O5S3
Mol. Mass.:
565.649
SMILES:
Nc1nc2c(cccc2s1)-c1ccc(c(c1-c1nnn[nH]1)S(N)(=O)=O)S(=O)(=O)NCC1(O)CCNCC1